Rafarma Pharmaceuticals, Inc. has signed a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia. Under the terms of the agreement, Rafarma and Vaccines Lab with create a new jointly-operated vaccine facility in Indonesia to research, develop, conduct clinical trials and license for various in-demand vaccines to combat several viruses. The joint venture will combine the expertise of Vaccines Lab and RAFARMA with its PJSC Kraspharma (OJSC Krasfarma) and R. & D. Biocogency Laboratories Inc. Rafarma plans to continue to aggressively pursue vaccine development with joint venture partners worldwide.